MERUS N V's ticker is MRUS and the CUSIP is N5749R100. A total of 44 filers reported holding MERUS N V in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $106,000 | -25.4% | 8,800 | 0.0% | 0.01% | -37.5% |
| Q2 2020 | $142,000 | +4633.3% | 8,800 | +3726.1% | 0.01% | – |
| Q4 2019 | $3,000 | -50.0% | 230 | -29.0% | 0.00% | – |
| Q3 2019 | $6,000 | +20.0% | 324 | -10.7% | 0.00% | – |
| Q2 2019 | $5,000 | -16.7% | 363 | -4.0% | 0.00% | – |
| Q1 2019 | $6,000 | +20.0% | 378 | +7.4% | 0.00% | – |
| Q4 2018 | $5,000 | -28.6% | 352 | 0.0% | 0.00% | – |
| Q3 2018 | $7,000 | – | 352 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 1,600,000 | $32,048,000 | 13.34% |
| Lynx1 Capital Management LP | 613,071 | $12,280,000 | 11.08% |
| Aquilo Capital Management, LLC | 1,507,109 | $30,187,000 | 10.88% |
| COMMODORE CAPITAL LP | 2,615,762 | $52,394,000 | 8.42% |
| MPM BioImpact LLC | 918,310 | $18,394,000 | 4.36% |
| BVF INC/IL | 3,444,420 | $68,992,000 | 2.85% |
| Boxer Capital, LLC | 1,900,000 | $38,057,000 | 2.14% |
| Opaleye Management Inc. | 253,200 | $5,072,000 | 2.10% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 295,136 | $5,912,000 | 2.00% |
| TCG Crossover Management, LLC | 300,000 | $6,009,000 | 1.80% |